You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Retroviral Agents

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in San Diego (Digital Health Feedback System)

Active, not recruiting
  • HIV
  • Digital Health Feedback System
  • San Diego, California
  • +1 more
Dec 21, 2022

HIV-1 Infection Trial in Berlin, Bucharest (MK-8558)

Completed
Has Results
  • HIV-1 Infection
  • Berlin, Germany
  • +1 more
May 5, 2021

Human Immunodeficiency Virus Trial in Pietermaritzburg (START Together)

Active, not recruiting
  • Human Immunodeficiency Virus
  • START Together
  • Pietermaritzburg, KwaZulu-Natal, South Africa
    Human Sciences Research Council
Nov 9, 2022

Osteoarthritis, Knee Trial in Vail (Fisetin, Losartan, Placebo - Losartan)

Recruiting
  • Osteoarthritis, Knee
  • Vail, Colorado
    The Steadman Clinic
Oct 6, 2022

Smoking, Smoking Cessation, HIV Trial in Miami (Nicoderm C-Q Transdermal Product, Adherence to Antiretroviral Therapy

Completed
Has Results
  • Smoking
  • +2 more
  • Nicoderm C-Q Transdermal Product
  • +4 more
  • Miami, Florida
    University of Miami
Nov 5, 2021

Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)

Recruiting
  • Treatment Resistant Depression
  • +12 more
  • Brooklyn, New York
    Maimonides Medical Center
Dec 12, 2022

HIV-1-infection, HIV Seropositivity Trial in Gent (Leucapheresis)

Not yet recruiting
  • HIV-1-infection
  • HIV Seropositivity
  • Leucapheresis
  • Gent, Oost-Vlaanderen, Belgium
    UZ Gent
Jul 25, 2023

HIV-1-infection, HIV, PD-L1 Gene Mutation Trial in Beijing (ASC22 1mg/kg, ASC22 2.5mg/kg, Antiretroviral Therapy)

Recruiting
  • HIV-1-infection
  • +2 more
  • ASC22 1mg/kg
  • +3 more
  • Beijing, Beijing, China
    The FifthMedical Center of the General Hospital of thePeoples Li
Jun 28, 2022

HIV-1-infection Trial in Kisumu, Nairobi (Switch to B/F/TAF, Continue current regimen)

Active, not recruiting
  • HIV-1-infection
  • Switch to B/F/TAF
  • Continue current regimen
  • Kisumu, Kenya
  • +1 more
May 24, 2022

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

PTSD, Alcohol Use Disorder Trial in Baltimore (Pregabalin plus BBCET, Placebo plus BBCET)

Active, not recruiting
  • PTSD
  • Alcohol Use Disorder
  • Pregabalin plus BBCET
  • Placebo plus BBCET
  • Baltimore, Maryland
    University of Maryland School of Medicine
Mar 25, 2022

Clinical Trials of Investigational or Licensed Vaccines or

Recruiting
  • Vaccines
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Collateral Damage From COVID-19 Pandemic Observed in Patients

    Completed
    • Age Related Macular Degeneration
    • +2 more
    • Questionnaire
    • Data collection up to 1 year
    • Ecully, France
    • +3 more
    Mar 2, 2022

    Anti-HLA Immunization And Immunosuppressive Therapy Management

    Active, not recruiting
    • Kidney Transplantation
    • +3 more
    • management of immunosuppressive therapy
    • Nancy, Lorraine, France
      Central HNF
    Mar 24, 2022

    Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

    Not yet recruiting
    • Neoplasms
    • +2 more
    • Nivolumab Injection [Opdivo]
    • (no location specified)
    Jul 19, 2023

    Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

    Recruiting
    • Hepatocellular Carcinoma
    • Anti-angiogenic agents plus anti-PD-1/PD-L1 antibodies
    • Shanghai, Shanghai, China
      Zhongshan Hospital, Fudan University
    Jul 23, 2021

    The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

    Not yet recruiting
    • HIV Infection
    • Anti-HIV Agents
    • (no location specified)
    Nov 4, 2022

    Tissue Adhesion, Gynecologic Surgery Trial in Taipei (PROTAHERE Absorbable Adhesion Barrier, Hyalobarrier Gel, No treatment)

    Active, not recruiting
    • Tissue Adhesion
    • Gynecologic Surgery
    • PROTAHERE Absorbable Adhesion Barrier
    • +4 more
    • Taipei, Taiwan
      Taipei Veterans General Hospital
    Jan 5, 2022

    Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

    Terminated
    Has Results
    • Cancer
    • Solid Tumors
    • Las Vegas, Nevada
    • +5 more
    Jun 14, 2022

    Ocular Adverse Events in Neovascular Age-related Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Alcohol Drinking, Alcohol-Related Disorders, Disease Trial in Catonsville (Minocycline, Sugar pill)

    Recruiting
    • Alcohol Drinking
    • +15 more
    • Catonsville, Maryland
      Maryland Psychiatric Research Center (MPRC) Treatment Research P
    Nov 29, 2022

    Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio

    Completed
    • Type 2 Diabetes
    • Sitagliptin/metformin ( 50/500mg) Oral Tablet
    • Empagliflozin/metformin(10/500mg) Oral Tablet
    • Baqubah, Diyala, Iraq
      College of Medicine, University of Diyala
    Apr 7, 2023

    Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Chuo-ku, Tokyo, Japan
      National Cancer Center Hospital ( Site 3700)
    Jan 31, 2023

    Advanced Solid Malignancies Trial in Worldwide (AZD9574, Temozolomide)

    Recruiting
    • Advanced Solid Malignancies
    • La Jolla, California
    • +30 more
    Dec 20, 2022

    Tuberculous Lymphadenitis Trial in Taipei (Prednisolone, standard anti-tuberculosis agents)

    Recruiting
    • Tuberculous Lymphadenitis
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 17, 2023